Article, see p 1632 I mpaired contractile function is the hallmark of systolic heart failure (HF). However, the exact mechanisms are not fully understood, and the resulting morbidity and mortality remain high despite significant advances in pharmacological and device therapies.
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Communication between subcellular organelles is extensive in eukaryotic cells, involving plasma membrane, endoplasmic reticulum, mitochondria, nucleus, and other organellar structures through specialized membrane domains in close proximity to one another. 4 This communication relies on different protein entities, depending on the organelles involved, and controls key cellular processes in a spatial and temporal fashion including cell death, metabolism, and gene expression. 4 An example of interorganellar communication in cardiomyocytes is the important interaction of sarcolemma with SR during excitation-contraction (EC) coupling. 5, 6 In this case, the transverse tubular system (T system) is the specialized membrane penetrating into the cardiomyocyte interior as an extensive network of T tubules which allows a rapid and synchronized transmission of the membrane action potential. Activation of Ltype Ca 2+ channels in the transverse tubule allows small amounts of Ca 2+ into the cytosol, a quantity insufficient by itself to activate a contractile response. Rather, this Ca 2+ acts as a messenger to trigger the release of Ca 2+ from the SR to reach a critical [Ca 2+ ] threshold and initiate a contractile response. 5 This structural and functional Ca 2+ microdomain (called couplon) comprises elements of the sarcolemma (≥1 voltage-gated L-type Ca 2+ channels in the T system) and a group of type 2 ryanodine receptors (RyR2) in the SR. 5 This junction spans ≈12 nm. 7 Alterations of Ca 2+ transients are a common feature of cardiomyocytes from failing myocardium and are thought to contribute to the progression of HF. 8 Moreover, in cardiomyocytes isolated from ventricles recovering contractile function by means of left ventricular assist device (LVAD) support, these abnormalities in Ca 2+ cycling have been demonstrated to improve. 9 Myocardial reverse remodeling is a complex phenotype marked by dynamic changes at multiple levels impacting cardiomyocyte contractile force and ventricular size and function. 10 When the therapy of maximal mechanical unloading is superimposed on a program of HF therapies proven to impact reverse remodeling, improvement in
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The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association. myocardial function can be significant, with a subset of these patients able ultimately to be weaned from LVAD support. 11 It is in this context that the groundbreaking study of Seidel and colleagues 12 in the current issue of Circulation has advanced our knowledge of subcellular membrane systems and their biological importance in myocardial remodeling (Figure) .
In their previous work with a canine model of dyssynchronous heart failure, Li and colleagues 13 showed that T-system depletion was accompanied by increased abundance of nonjunctional RyR clusters uncoupled from the L-type Ca 2+ channels. 13 Remarkably, applying cardiac resynchronization therapy to induce myocardial reverse remodeling, they found that the T-system depletion was reversible and associated with restoration of Ca 2+ transients. In an extension of these studies into human HF, Seidel and colleagues used fluorescent staining, confocal microscopy, and 3-dimensional image analysis to investigate the T-system structure, density, and distance between RyR clusters and the sarcolemma in fixed myocardium, in isolated cardiomyocytes from unused donor hearts, and in chronic HF patients undergoing implantation of an LVAD. 12 They showed for the first time that: (1) a novel structural phenotype of the T tubules (a sheetlike T system rather than tubular membrane invaginations of the sarcolemma) in human cardiomyocytes from end-stage failing myocardium was associated with an increased distance separating RyR and the sarcolemma, heterogeneous intracellular Ca 2+ release, and impaired EC coupling. (2) A tight relationship between the structure of the T system and the effectiveness of mechanical unloading in affecting recovery of function. High degrees of T-system remodeling (increased RyR sarcolemma separation) at the time of LVAD implantation were associated with absence of functional cardiac recovery during mechanical unloading, whereas preserved T-system structure was associated with recovery. Remarkably, the left ventricular ejection fraction in patients with pre-LVAD RyR-sarcolemma distances >1 μm did not improve following a period of mechanical unloading. This study has identified an important ultrastructural signature in human failing myocardium, and possibly a sine qua non of the end-stage failing heart. Nevertheless, some key questions arise from this landmark study.
1. Do we need further confirmation that this pattern of the T-tubule system is a signature of the end-stage failing heart? If one could induce in an animal model a disrupted T-tubule system and compromise the functionality of this interconnected membrane system, would this result in progressive myocardial remodeling toward advanced stage HF? Alternatively, future studies using superresolution imaging could corroborate the exact ultrastructural remodeling of the T-system with techniques such as stimulated emission depletion microscopy. 2. If sheet-like T-tubule remodeling is a necessary condition for defining the end-stage failing myocardium, is it also sufficient? That is, in patients with chronic cardiomyopathy at an earlier stage of the HF syndrome, does the presence of this T-system disruption imply obligate disease progression and portend inability of reverse remodeling with therapies that include mechanical unloading. Earlier intervention with modalities that reverse HF may be the key to providing a robust and durable recovery, because the study also found that the patients with the shortest duration of HF were more likely to have preserved T-system structure and function. In a recently convened National Heart, Lung and Blood Institute working group on myocardial recovery with mechanical unloading, a top priority included the study of mechanisms behind the durable remission from HF and how this could be achieved. 14 3. If this pattern is confirmed to be that of an endstage failing heart, do we have a structural basis for a more informed, personalized targeting of therapies for advanced HF? This novel phenotype of T-sheet ultrastructural remodeling of the membrane systems that regulate Ca 2+ within the cardiomyocyte can be used for a tailored approach to maximize survival before and after advanced therapies in patients with presumed end-stage HF. The patients with advanced HF who have intact and preserved T-tubule structure may have the potential for myocardial recovery on a platform of mechanical circulatory support. In these patients, clinicians can apply maximal mechanical unloading along with standard HF therapies with the possible addition of experimental therapies to maximize the likelihood of myocardial reverse remodeling and achieve a remission or recovery from end-stage HF. This bridge to recovery may not be possible in the patients with sheet-like remodeling of the T-tubule membrane system, because patients with this ultrastructural signature demonstrated a very limited degree of myocardial reverse remodeling with mechanical unloading. It must be noted, however, that remodeling toward a more functional T-tubule system could still take place with other therapies that reverse HF but not, as Seidel and colleagues 12 have convincingly demonstrated, with left ventricular mechanical unloading. Given the evidence that both loading and unloading impact the structure and function of T tubules, 15 it is not surprising that therapies targeting the mechanical transduction of load may not reverse the subcellular abnormalities within the T system. Future work could determine whether therapies that lead to recovery of other deficits (metabolic, adrenergic receptor signaling, etc) and improve functionality also impact the remodeling of the T-system and couplon density. 4. Does this pattern of T-tubule system remodeling in the advanced stage of HF also occur in the less pressurized right ventricle? If so, can it provide a cellular biomarker helpful in predicting whether the right ventricle can withstand long-term LVAD support and allow survival without late right HF. Irrespective of how these scenarios play out, this work by Seidel and colleagues has reinvigorated a fundamental question in human biology: how do we know a failing organ has reached end-stage, especially an organ such as the heart with functional capacity that is very load sensitive? In doing so, their work has illuminated the cardiomyocyte ultrastructure as an essential starting point for all to consider in elucidating the molecular basis of myocardial recovery.
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FOOTNOTES
Circulation is available at http://circ.ahajournals.org. Figure Continued. level, a regression in cardiomyocyte hypertrophy with a reduction cardiomyocyte cross-sectional area after a period of mechanical unloading with both pulsatile and continuous-flow devices has been confirmed by several studies. Electron microscopy of the cardiomyocyte ultrastructure has revealed sheet-like remodeling of the T-tubule membrane system (in blue) in patients with end-stage heart failure, resulting in a disruption of the coupling or dyad distance between the ryanodine receptor type 2 (RyR2, green) of the sarcoplasmic reticulum (also in green) and the L-type calcium channel (purple) of the T-tubular membrane, critical in maintaining calcium-induced calcium release and synchronous excitation-contraction coupling. Patients who have end-stage heart failure with this ultrastructural signature of detubulation into a T-sheet membrane system did not demonstrate myocardial reverse remodeling with a program of LVAD-induced mechanical unloading, raising the possibility that disruption of this membrane system to this degree precludes recovery of ventricular function with mechanical assist device support.
